GET THE APP

PPIs long term safety. What should we know as clinicians? What sh | 20183
Journal of Hepatology and Gastrointestinal disorders

Journal of Hepatology and Gastrointestinal disorders
Open Access

ISSN: 2475-3181

+44-20-4587-4809

PPIs long term safety. What should we know as clinicians? What should we tell our patients?


17th International Conference on Gastroenterology and Hepatology

September 03-04, 2018 Dubai, UAE

Sanae Reggoug

Al Garhoud Private Hospital, UAE

Scientific Tracks Abstracts: J Hepatol Gastroint Dis

Abstract :

Proton Pump Inhibitors (PPI) is amongst the most commonly prescribed medications worldwide. Long term use of PPI is indicated in some clinical situations such as severe gastro-esophageal reflux disease and prophylaxis purpose in patients using non-steroidal anti-inflammatory drugs. PPIS safety profile was considered very well till recent years. A systematic medical literature search through Pubmed, using keywords PPI, safety, long term and risk, revealed not less than 300 publications related to PPI safety since the beginning of year 2017. These medical publications received considerable attention from media and strongly affected not only patient´┐Ż??s therapeutic compliance but also prescribers practice. During this evidence-based presentation, the safety of long term use of PPIs will be examined and guidance will be provided on what clinicians need to know and what to tell their patients. A critical and objective analysis of the studies on PPIs safety will be demonstrated, highlighting epidemiological limitations and methodological concerns.

Biography :

Sanae Reggoug is a Board Certified Gastroenterologist and Hepatologist. She has been practicing in Dubai since 2014 and is currently working at Al Garhoud Private Hospital, in Dubai. After graduation from University Mohamed V in Rabat (Morocco), she completed her gastroenterology and digestive endoscopy fellowship in the University of Rennes in France, one of Europe most renowned excellence center for Hepatology, Proctology and Inflammatory Bowel Diseases. Dr Sanae is also subspecialized in medical and instrumental proctology and holder of a diploma in medico-instrumental proctology from the French Society of Colo-Proctology. She has as well a special interest in digestive oncology and is holding a diploma in digestive oncology delivered from the University of Versailles Saint-Quentin-en-Yvelines (Paris, France). Actively involved in clinical research, Dr Sanae has several articles published in several peer-reviewed journals, such as American Journal of Gastroenterology.

E-mail: reggoug.sanae@hotmail.com

 

Top